List of Excipients in API sotagliflozin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sotagliflozin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | CROSCARMELLOSE SODIUM | 2028-05-26 |
| Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | FD&C BLUE NO. 2 | 2028-05-26 |
| Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | MAGNESIUM STEARATE | 2028-05-26 |
| Lexicon Pharmaceuticals Inc | INPEFA | sotagliflozin | 70183-220 | MICROCRYSTALLINE CELLULOSE 102 | 2028-05-26 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for sotagliflozin
Excipient focus: CROSCARMELLOSE SODIUM
sotagliflozin drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
sotagliflozin drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
sotagliflozin drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
sotagliflozin drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 200
sotagliflozin drug variants containing MICROCRYSTALLINE CELLULOSE 200
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing MICROCRYSTALLINE CELLULOSE 200
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
sotagliflozin drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
sotagliflozin drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
sotagliflozin drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
sotagliflozin drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
sotagliflozin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lexicon Pharmaceuticals Inc | sotagliflozin | 70183-220 |
| >Company | >Ingredient | >NDC |
sotagliflozin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch